The global single-use bioprocessing market is segmented on the basis of product, application, method, end user, and geography. Based on product, it is divided into bioreactors, tangential-flow filtration devices, depth filters, disposable filter cartridges, media bags & containers, mixing systems, tubing assemblies, sampling systems, and other products. Based on application, it is classified into monoclonal antibody production, vaccine production, plant cell cultivation, patient specific cell therapies, and others. Based on method, it is categorized into filtration, storage, cell culture, mixing, and purification. Based on end user, it is classified into biopharmaceutical manufacturers, life science R&D companies & academic research institutes, and contract research organizations & manufacturers. The media bags & assemblies segment generated the highest revenue in 2016, registering a CAGR of 18.1% from 2017 to 2023, and is anticipated to continue its dominance throughout the forecast period. In addition, single-use bioprocessing technologies are used in the production of monoclonal antibodies (mAb), and has generated the highest revenue in this application throughout the forecast period.
Geographically, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA. In the recent years, Asia-Pacific has witnessed rapid growth in the single-use bioprocessing market This is attributed to the increasing adoption of single-use technologies by small biotechnology startups and biopharmaceutical companies in bioprocessing. In addition, several market players have focused on developing novel single use products for bio-manufacturing driving the market growth.
KEY BENEFITS FOR STAKEHOLDERS
The study provides an in-depth analysis of the global single-use bioprocessing market along with the current trends and future estimations to elucidate the imminent investment pockets.
Comprehensive analysis of the factors that drive and restrict the market growth is provided in the report.
Comprehensive quantitative analysis of the industry is provided for the period of 2016–2023 to assist stakeholders to capitalize on the prevailing market opportunities.
Extensive analysis of the key segments of the industry helps in understanding the trends in products and technologies across the globe.
Key market players and their strategies have been provided to understand the competitive outlook of the industry.
KEY MARKET SEGMENTS
Tangential-flow Filtration Devices
Disposable Filter Cartridges
Media Bags & Containers
Monoclonal Antibody Production
Plant Cell Cultivation
Patient Specific Cell Therapies
By End User
Life Science R&D Companies & Academic Research Institutes
Contract Research Organizations & Manufacturers
Rest of Europe
Rest of Asia-Pacific
Rest of LAMEA
KEY MARKET PLAYERS
Thermo Fisher Scientific
GE Healthcare (General Electric Company)
Sartorius Stedim Biotech S.A.
Merck Millipore (Merck Group)
Finesse Solutions, Inc.
Applikon Biotechnology B.V.
Cesco Bioengineering Co., Ltd.
The other players in the value chain include (profiles not included in the report)
Octane Biotech Inc.
PBS Biotech, Inc.
Meissner Filtration Products, Inc.
Sentinel Process Systems Inc.
CMC Biologics (Asahi Glass Co.)
BioPure Technology Ltd.
1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models
CHAPTER 2 EXECUTIVE SUMMARY
2.1. CXO PERSPECTIVE
CHAPTER 3 MARKET OVERVIEW
3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS
3.2.1. Top investment pockets
3.2.2. Top winning strategies
3.3. PORTERS FIVE FORCES ANALYSIS
3.4. REGULATORY FRAMEWORK
3.5. MARKET SHARE ANALYSIS, 2016
3.6. MARKET DYNAMICS
184.108.40.206. Increase in demand for single use technologies in biomanufacturing
220.127.116.11. Rise in adoption of SUT for continuous manufacturing
18.104.22.168. Lower risk of cross-contamination and reduced manufacturing cost
22.214.171.124. Increasing demand for flexible bioprocessing equipment and less floor space requirement
126.96.36.199. Concerns regarding extractability and leachability issues
188.8.131.52. Stringent regulations regarding use of disposable bioprocessing systems
184.108.40.206. Untapped developing regions
CHAPTER 4 SINGLE-USE BIOPROCESSING MARKET, BY PRODUCT
4.1.1. Market size and forecast
4.2.1. Key market trends
4.2.2. Growth factors and opportunities
4.2.3. Market size and forecast
4.3. TANGENTIAL-FLOW FILTRATION DEVICES
4.3.1. Key market trends
4.3.2. Growth factors and opportunities
4.3.3. Market size and forecast
4.4. DEPTH FILTERS
4.4.1. Key market trends
4.4.2. Growth factors and opportunities
4.4.3. Market size and forecast
4.5. DISPOSABLE FILTER CARTRIDGES
4.5.1. Key market trends
4.5.2. Growth factors and opportunities
4.5.3. Market size and forecast
4.6. MEDIA BAGS & CONTAINERS
4.6.1. Key market trends
4.6.2. Growth factors and opportunities
4.6.3. Market size and forecast
4.7. MIXING SYSTEMS
4.7.1. Key market trends
4.7.2. Growth factors and opportunities
4.7.3. Market size and forecast
4.8. TUBING ASSEMBLIES
4.8.1. Key market trends
4.8.2. Growth factors and opportunities
4.8.3. Market size and forecast
4.9. SAMPLING SYSTEMS
4.9.1. Key market trends
4.9.2. Growth factors and opportunities
4.9.3. Market size and forecast
4.10. OTHER PRODUCTS
4.10.1. Key market trends
4.10.2. Growth factors and opportunities
4.10.3. Market size and forecast
CHAPTER 5 SINGLE-USE BIOPROCESSING MARKET, BY APPLICATION
5.1.1. Market size and forecast
5.2. MONOCLONAL ANTIBODY PRODUCTION
5.2.1. Market size and forecast
5.3. VACCINE PRODUCTION
5.3.1. Market size and forecast
5.4. PLANT CELL CULTIVATION
5.4.1. Market size and forecast
5.5. PATIENT SPECIFIC CELL THERAPIES
5.5.1. Market size and forecast
5.6. OTHER APPLICATIONS
5.6.1. Market size and forecast
CHAPTER 6 SINGLE-USE BIOPROCESSING MARKET, BY METHOD
6.1.1. Market size and forecast
6.2.1. Market size and forecast
6.3.1. Market size and forecast
6.4. CELL CULTURE
6.4.1. Market size and forecast
6.5.1. Market size and forecast
6.6.1. Market size and forecast
CHAPTER 7 SINGLE-USE BIOPROCESSING MARKET, BY END USERS
7.1.1. Market size and forecast
7.2. BIOPHARMACEUTICAL MANUFACTURERS
7.2.1. Market size and forecast
7.3. LIFE SCIENCE R&D COMPANIES & ACADEMIC RESEARCH INSTITUTES
7.3.1. Market size and forecast
7.4. CONTRACT RESEARCH ORGANIZATIONS & MANUFACTURERS
7.4.1. Market size and forecast
CHAPTER 8 SINGLE-USE BIOPROCESSING MARKET, BY GEOGRAPHY
8.1.1. Market size and forecast
8.2. NORTH AMERICA
8.2.1. Key market trends
8.2.2. Key growth factors and opportunities
8.2.3. Market size and forecast
220.127.116.11. U.S. market size and forecast
18.104.22.168. Mexico market size and forecast
22.214.171.124. Canada market size and forecast
8.3.1. Key market trends
8.3.2. Key growth factors and opportunities
8.3.3. Market size and forecast
126.96.36.199. UK market size and forecast
188.8.131.52. France market size and forecast
184.108.40.206. Germany market size and forecast
220.127.116.11. Italy market size and forecast
18.104.22.168. Spain market size and forecast
22.214.171.124. Rest of Europe market size and forecast
8.4.1. Key market trends
8.4.2. Key growth factors and opportunities
8.4.3. Market size and forecast
126.96.36.199. Japan market size and forecast
188.8.131.52. China market size and forecast
184.108.40.206. India market size and forecast
220.127.116.11. Australia market size and forecast
18.104.22.168. Rest of Asia-Pacific market size and forecast
8.5.1. Key market trends
8.5.2. Key growth factors and opportunities
8.5.3. Market size and forecast
22.214.171.124. Brazil market size and forecast
126.96.36.199. Turkey market size and forecast
188.8.131.52. Argentina market size and forecast
184.108.40.206. South Africa market size and forecast
220.127.116.11. Rest of LAMEA market size and forecast
CHAPTER 9 COMPANY PROFILES
9.1. THERMO FISHER SCIENCTIFIC
9.1.1. Company overview
9.1.2. Company snapshot
9.1.3. Operating business segments
9.1.4. Business performance
9.1.5. Key strategic moves and developments
9.2. DANAHER CORPORATION
9.2.1. Company overview
9.2.2. Company snapshot
9.2.3. Operating business segments
9.2.4. Business performance
9.2.5. Key strategic moves and developments
9.3. GE HEALTHCARE
9.3.1. Company overview
9.3.2. Company snapshot
9.3.3. Operating business segments
9.3.4. Business performance
9.3.5. Key strategic moves and developments
9.4. SARTORIUS STEDIM BIOTECH S.A
9.4.1. Company overview
9.4.2. Company snapshot
9.4.3. Operating business segments
9.4.4. Business performance
9.4.5. Key strategic moves and developments
9.5. MERCK MILIPORE
9.5.1. Company overview
9.5.2. Company snapshot
9.5.3. Operating business segments
9.5.4. Business performance
9.5.5. Key strategic moves and developments
9.6. 3M COMPANY
9.6.1. Company overview
9.6.2. Company snapshot
9.6.3. Operating business segments
9.6.4. Business performance
9.6.5. Key strategic moves and developments
9.7. EPPENDORF AG
9.7.1. Company overview
9.7.2. Company snapshot
9.7.3. Operating business segments
9.7.4. Business performance
9.7.5. Key strategic moves and developments
9.8. FINESSE SOLUTIONS, INC.
9.8.1. Company overview
9.8.2. Company snapshot
9.8.3. Operating business segments
9.8.4. Business performance
9.8.5. Key strategic moves and developments
9.9. APPLIKON BIOTECHNOLOGY
9.9.1. Company overview
9.9.2. Company snapshot
9.9.3. Operating business segments
9.9.4. Business performance
9.9.5. Key strategic moves and developments
9.10. CESCO BIOENGINEERING C0. LTD.
9.10.1. Company overview
9.10.2. Company snapshot
9.10.3. Operating business segments
9.10.4. Business performance
9.10.5. Key strategic moves and developments
Single-use bioprocessing technology has gained significant traction in the recent years, owing to the rapid adoption of disposable bioprocessing equipment by pharmaceutical manufacturers. These products have also proved beneficial for the small scale pharmaceutical manufacturers. Hence, most biopharmaceutical companies utilize single-use bioprocessing technology for manufacturing vaccines, monoclonal antibodies, and other pharmaceutical components on commercial scale.
Rise in adoption of single use technologies, lower risk of product cross-contamination, and less floor space requirement drive the single-use bioprocessing market. In addition, single-use bioprocessing technologies are highly efficient and cost-effective, which attracts the pharmaceutical manufacturers to adopt disposable bioprocessing products, thus propelling the demand for single-use bioprocessing technologies. However, extractability and leachability issues and stringent regulations restrain the market growth. Moreover, untapped markets, such as China and India, offers profitable opportunities for the expansion of this market.
The filtration segment generated highest revenue exhibiting one-third of the total share of the single-use bioprocessing market in 2016. Single-use bioprocessing technology penetrated in the pharmaceutical industry through disposable filtration systems and is the crucial part of bioprocessing procedure. This leads to the high demand for single use filtration products catering to the market growth. In addition, single-use bioprocessing systems are employed in the production of monoclonal antibody production (mAb), making it a leading application of single-use bioprocessing market. The mAb application accounted for two-fifths of the global single-use bioprocessing market in 2016. However, utilization of single-use bioprocessing systems in patient specific cell therapies has gained momentum in the recent year, and is expected to maintain this trend in the near future with the highest CAGR of 19.9% from 2017 to 2023. Moreover, the biopharmaceutical manufacturers segment accounted for approximately half of the total market share among all the end users of the global single-use bioprocessing market.
Key Findings of the Single-use Bioprocessing Market:
The bioreactors segment is anticipated to grow at a rapid rate, registering a CAGR of 20.2% from 2017 to 2023.
The vaccine production is the second largest application of global single-use bioprocessing market in 2016, and is expected to grow at a CAGR of 19.5% during the forecast period.
North America dominated the single-use bioprocessing market, accounting for maximum share of overall market in 2016.
Asia-Pacific is exhibited to grow at a high rate of 20.2%, owing to the increase in demand for biopharmaceuticals.
India is the fastest growing country of Asia-Pacific single-use bioprocessing market in 2016, and is anticipated to maintain this during the forecast period.
The contract research organization & manufacturers segment is registered highest CAGR of 20.5%.
The tangential-flow filtration devices, depth filters, and disposable filter cartridges together represent one-fourth of the total market share.
The purification segment is the fastest growing method of single-use bioprocessing market registering a CAGR of 19.8%.
Asia-Pacific witnessed highest growth rate for single-use bioprocessing market, and is expected to continue this trend throughout the forecast period attributed to the rise in expenditure on healthcare and improvement in medical and healthcare infrastructure. In addition, the key market players focus on the opportunities offered by the growing demand for single-use bioprocess systems. This system is highly cost-effective, which has gained popularity among end users. Moreover, significant growth of pharmaceutical and the biotechnology industries supplements the market growth.
The key players operating in the single-use bioprocessing market have adopted product launch as their key developmental strategy and focus on launching innovative products to cater to the consumer requirements and strengthen their market share. The major companies profiled in the report include Thermo Fisher Scientific, Danaher Corporation, GE Healthcare (General Electric Company), Sartorius Stedim Biotech S.A, Merck Millipore (Merck Group), 3M Company, Eppendorf AG, Finesse Solutions, Inc., Applikon Biotechnology B.V., and Cesco Bioengineering Co., Ltd.
- Thermo Fisher Scientific
- Danaher Corporation
- Ge Healthcare (General Electric Company)
- Sartorius Stedim Biotech S.A.
- Merck Millipore (Merck Group)
- 3M Company
- Eppendorf Ag
- Finesse Solutions, Inc.
- Applikon Biotechnology B.V.
- Cesco Bioengineering Co., Ltd.